MONELL CHEMICAL SENSES CENTER IMAGE: GLOBAL MAP OF TOOL FOR UP-TO-DATE AND CURRENT COVID-19 RESEARCH, SPECIFICALLY STUDIES THAT REPORT SMELL LOSS IN PATIENTS. PHILADELPHIA (October 12, 2020) – Smell loss is a frequently reported symptom of COVID-19 but reports of prevalence vary from study-to-study and range from 5% to 98%. With such a wide range...
by Samba Scientific In this study, which was published in the journal Frontiers in Immunology on September 30th, researchers used sequencing to characterize the immune system of patients who survive from COVID-19 infection from symptom onset through recovery. Importantly, they also identified a potent biomarker for predicting disease progression. Follow-up studies could lead to the development of a treatment...
Predicting the spread of COVID-19 with smart thermometers Kinsa’s predictive map of COVID-19 outbreaks on Oct. 14, with flashing lights indicating states where cases are projected to rise. A company that makes internet-connected thermometers has shown success in predicting likely COVID-19 hot spots days or even weeks before case counts rise. Why it matters: Even as the...
THE UNIVERSITY OF HONG KONG IMAGE: PROPOSED STRUCTURE OF BI-BOUND ZINC-BINDNIG DOMAIN OF SARS-COV-2 HELICASE. THROUGH KICKING OUT THE CRUCIAL ZINC(II) IONS IN THE ZINC-BINDING DOMAIN OF SARS-COV-2 HELICASE, RBC DEMONSTRATED ITS ABILITY TO POTENTLY SUPPRESS. A research team led by Professor Hongzhe SUN, Norman & Cecilia Yip Professor in Bioinorganic Chemistry, Department of Chemistry, Faculty of...
Antibodies made by the body to fight COVID-19 — the transfusion of which is being trialled as a treatment for other, more severe patients — fade rapidly after recovery. Experts from Canada studied the blood of recovering coronavirus patients, finding that the extent of the immune defences drop 6–10 weeks after their first symptoms. Plasma transfusions have not been...
A new study published on 8 October in the journal Clinical Epidemiology used data from the Office for National Statistics Coronavirus (COVID-19) Infection Survey on a representative population sample of 36,061 people living in England, Wales and Northern Ireland who were tested between 26 April and the 27 June 2020. According to the data, out of the...
by American Dental Association Although assumed to be at high risk for COVID-19, fewer than one percent of dentists nationwide were found to be COVID-19 positive, according to a first-of-its-kind report in the U.S. based on data collected in June 2020. The result is far below that of other health professionals in the U.S. In...
New research suggests that catalase, a naturally occurring enzyme in humans, plants, and animals, can suppress the replication of the new coronavirus in rhesus monkeys. The results also indicate that this low cost enzyme could dampen the inflammatory response that occurs in severe COVID-19. Above, a computer-generated illustration shows a cytokine storm, the excessive immune response that...
by La Jolla Institute for Immunology This scanning electron microscope image shows SARS-CoV-2 (round blue objects) emerging from the surface of cells cultured in the lab. As scientists around the world develop life-saving COVID-19 vaccines and therapies, many are still wondering exactly why the disease proves deadly in some people and mild in others. To solve...
It kills more people than the flu, contrary to Trump’s claims, and also surpasses stroke, Alzheimer’s and diabetes By Youyou Zhou, Gary Stix, October 8, 2020 “It affects virtually nobody,” President Donald Trump said of the novel coronavirus on September 21—a few hours before U.S. deaths from COVID-19 exceeded 200,000 and less than two weeks before...
